Primary cutaneous aspergillosis: our experience in 10 years.
We describe nine patients with primary cutaneous aspergillosis who were diagnosed during the 10-year period between 1987 and 1996. All except one were adults. Seven of those nine cases had an immunocompromised state. Among the immunocompromised patients, six had burn wounds and one was a renal transplant recipient. Aspergillus flavus was isolated from seven patients and A. fumigatus from one, and in one other case the species could not be determined. Three patients who had total burn surface area of more than 70% died. The other patients responded well to extensive surgical debridement with or without institution of oral itraconazole.
Chakrabarti
A
A
Department of Medical Microbiology, Postgraduate Institute of Medical Education & Research, Chandigarh, India.
Gupta
V
V
Biswas
G
G
Kumar
B
B
Sakhuja
V K
VK
D000328:Adult; D000935:Antifungal Agents / Q000627:therapeutic use; D001228:Aspergillosis / Q000175:diagnosis* / Q000382:microbiology / Q000628:therapy; D001231:Aspergillus flavus / Q000302:isolation & purification; D001232:Aspergillus fumigatus / Q000302:isolation & purification; D002056:Burns; D002058:Burns, Electric; D002648:Child; D003881:Dermatomycoses / Q000175:diagnosis* / Q000382:microbiology / Q000628:therapy; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D017964:Itraconazole / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology; D008297:Male
D000935:Antifungal Agents; D017964:Itraconazole